Claudin 19 Antikörper
-
- Target Alle Claudin 19 (CLDN19) Antikörper anzeigen
- Claudin 19 (CLDN19)
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Claudin 19 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC)
- Kreuzreaktivität
- Human, Maus, Ratte
- Aufreinigung
- Antigen affinity purification
- Immunogen
- Synthetic peptide of Human CLDN19
- Isotyp
- IgG
- Top Product
- Discover our top product CLDN19 Primärantikörper
-
-
- Applikationshinweise
- ELISA:1:2000-1:5000, IHC:1:25-1:100,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- -20 °C, pH 7.4 PBS, 0.05 % Sodium azide, 40 % Glycerol
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- Claudin 19 (CLDN19)
- Andere Bezeichnung
- CLDN19 (CLDN19 Produkte)
- Synonyme
- HOMG5 antikoerper, claudin-19 antikoerper, zgc:112141 antikoerper, claudin 19 antikoerper, claudin 19 S homeolog antikoerper, CLDN19 antikoerper, Cldn19 antikoerper, cldn19.S antikoerper, cldn19 antikoerper
- Hintergrund
-
Background: The product of this gene belongs to the claudin family. It plays a major role in tight junction-specific obliteration of the intercellular space, through calcium-independent cell-adhesion activity. Defects in this gene are the cause of hypomagnesemia renal with ocular involvement (HOMGO). HOMGO is a progressive renal disease characterized by primary renal magnesium wasting with hypomagnesemia, hypercalciuria and nephrocalcinosis associated with severe ocular abnormalities such as bilateral chorioretinal scars, macular colobomata, significant myopia and nystagmus. Alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene.
Aliases: CLDN19Claudin-19 antibody
- UniProt
- Q8N6F1
- Pathways
- Cell-Cell Junction Organization, Hepatitis C
-